|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $26,281,000 | $31,388,000 | $29,464,000 | $25,861,000 | $41,257,000 | $43,295,118 | $40,653,399 |
| Streptomycins & their derivs.; salts thereof | $2,446,000 | $2,099,000 | $1,176,000 | $734,000 | $903,000 | $3,063,078 | $3,868,895 |
| Tetracyclines & their derivs.; salts thereof | $46,460,000 | $40,752,000 | $21,688,000 | $20,124,000 | $32,888,000 | $29,503,320 | $34,987,944 |
| Chloramphenicol & its derivs.; salts thereof | $26,629,000 | $28,910,000 | $18,054,000 | $19,884,000 | $28,893,000 | $25,902,349 | $3,190,648 |
| Erythromycin & its derivs.; salts thereof | $18,229,000 | $23,085,000 | $9,829,000 | $11,433,000 | $7,513,000 | $4,936,430 | $7,239,917 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $883,066,000 | $955,291,000 | $806,725,000 | $706,564,000 | $816,837,000 | $796,328,631 | $1,024,469,535 |
| Total | $1,003,111,000 | $1,081,525,000 | $886,936,000 | $784,600,000 | $928,291,000 | $903,028,926 | $1,114,410,338 |
|
|
